Although anti-PD-L1 monotherapy had little effect, anti-PD-L1 + IgG2a anti-TIGIT combination treatment inflamed tumour macrophages, amplifying the antigen-presentation gene program induced by anti-TIGIT antibodies alone (Fig. 4b). The gene discussed is TIGIT; the disease is neoplasm.